Position in SRRK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$151,458,285
+$45,811,676 QoQ
Shares Held
2,753,787
+28.1% QoQ
Ownership
2.26%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#12
of 304 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SRRK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. SRRK ranks #37 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in SRRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $151,458,285 | 2,753,787 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $105,646,609 | 2,149,036 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $89,598,757 | 2,034,024 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $72,797,123 | 1,954,810 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $66,852,062 | 1,887,410 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $59,395,485 | 1,847,449 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $76,513,403 | 1,770,324 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $12,359,629 | 1,543,025 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $11,849,724 | 1,422,536 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $21,156,706 | 1,191,256 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $21,461,083 | 1,141,547 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $6,056,811 | 853,072 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,043,159 | 668,854 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,989,064 | 373,633 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,287,285 | 363,236 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,487,620 | 358,964 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,469,195 | 267,613 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $6,185,666 | 479,881 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $11,621,791 | 467,866 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $14,170,103 | 429,137 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $11,962,577 | 413,930 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $20,273,878 | 400,195 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $17,718,254 | 365,099 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $5,257,679 | 297,212 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,296,141 | 290,837 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,057,145 | 252,448 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||